InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
Go back to InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds| (NASDAQ: INCR) | Delayed: 0.97 +0.02 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.95 | 52 Week High | $57.11 | |||
| Open | $0.89 | 52 Week Low | $34.19 | |||
| Day High | $0.97 | P/E | N/A | |||
| Day Low | $0.89 | EPS | $0.00 | |||
| Volume | 13,232 | |||||
| (NASDAQ: INCR) | Delayed: 0.97 +0.02 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.95 | 52 Week High | $57.11 | |||
| Open | $0.89 | 52 Week Low | $34.19 | |||
| Day High | $0.97 | P/E | N/A | |||
| Day Low | $0.89 | EPS | $0.00 | |||
| Volume | 13,232 | |||||

